{"organizations": [], "uuid": "f22174cc9ae17f46fb45c3846e699f95b60f4d77", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bioceres-sa-sees-us-ipo-of-up-to-1/brief-bioceres-s-a-sees-u-s-ipo-of-up-to-11-82-mln-ordinary-shares-idUSFWN1PI120", "country": "US", "domain_rank": 408, "title": "BRIEF-Bioceres S.A. Sees U.S. IPO Of Up To 11.82 mln Ordinary Shares", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-24T00:47:00.000+02:00", "replies_count": 0, "uuid": "f22174cc9ae17f46fb45c3846e699f95b60f4d77"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bioceres-sa-sees-us-ipo-of-up-to-1/brief-bioceres-s-a-sees-u-s-ipo-of-up-to-11-82-mln-ordinary-shares-idUSFWN1PI120", "ord_in_thread": 0, "title": "BRIEF-Bioceres S.A. Sees U.S. IPO Of Up To 11.82 mln Ordinary Shares", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bioceres s.a.", "sentiment": "negative"}, {"name": "brief-bioceres s.a.", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - Bioceres S.A.\n* BIOCERES S.A. SEES U.S. IPO OF UP TO 11.82 MILLION ORDINARY SHARES MAY BE REPRESENTED BY AMERICAN DEPOSITARY SHARES - SEC FILING\n* BIOCERES S.A. SAYS ESTIMATED U.S. IPO PRICE IS BETWEEN US$10.00 AND US$12.00 PER ADS\n* BIOCERES S.A. SAYS INTENDS TO USE ABOUT $15.3 MILLION OF IPO PROCEEDS TO REPAY ALL OR PORTION OF OUTSTANDING DEBT\n* BIOCERES S.A. SAYS INTENDS TO USE ABOUT $10.0 MILLION OF IPO PROCEEDS FOR INVESTMENTS IN SEED AND INTEGRATED PRODUCTS SEGMENT\n* BIOCERES S.A. SAYS INTENDS TO USE ABOUT $5.0 MILLION OF IPO PROCEEDS FOR INVESTMENTS IN COMMERCIALLY EXPANDING AGRO-INDUSTRIAL BIOTECH SOLUTIONS BUSINESS\n* BIOCERES S.A. SAYS INTENDS TO USE ABOUT $15.0 MILLION OF IPO PROCEEDS TO EXERCISE MANDATORY CALL OPTION FOR ADDITIONAL 9.99% OF RIZOBACTER Source text : bit.ly/2G7XQIS\n ", "external_links": ["http://bit.ly/2G7XQIS", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T00:47:00.000+02:00", "crawled": "2018-01-24T15:21:00.001+02:00", "highlightTitle": ""}